$100 Invested In Moderna 10 Years Ago Would Be Worth This Much Today

Moderna MRNA has outperformed the market over the past 10 years by 32.49% on an annualized basis producing an average annual return of 43.18%. Currently, Moderna has a market capitalization of $70.24 billion.

Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 10 years ago, it would be worth $3,619.70 today based on a price of $182.83 for MRNA at the time of writing.

Moderna's Performance Over Last 10 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-PODEarningsNewsDividends